Pores and skin and smooth tissue infections, reminiscent of cellulitis, are generally identified within the emergency division and these sufferers are sometimes admitted to the hospital for intravenous antibiotic remedy. Oritavancin is a novel antibiotic authorised for the remedy of pores and skin and smooth tissue infections that’s administered as a one-time infusion.
Whereas oritavancin has demonstrated comparable efficacy with multi-dose parenteral antibiotics in scientific trials and has been proposed as a substitute for admission for emergency division sufferers, there’s a paucity of accessible actual world effectiveness knowledge. On this case sequence, we describe the traits and outcomes of ten sufferers with high-risk pores and skin and smooth tissue infections who acquired oritavancin and have been discharged from the emergency division.
Relationship between dose and stopping energy values for electrons in pores and skin and muscle tissues
Absorbed dose and stopping energy of the goal materials are two essential parameters for figuring out the radiation results. On this work, the connection between these two parameters has been investigated for electron beams incident on pores and skin and muscle tissue.
Absorbed dose was obtained through the use of the EGSnrc code and the stopping energy values have been calculated by contemplating the velocity-depended efficient cost and imply excitation values. To acquire the connection between absorbed dose and stopping energy values, these parameters have been graphed collectively and easy becoming capabilities have been obtained. The outcomes obtained present that these parameters are linearly correlated with one another.
Phenotypic and genotypic virulence options of staphylococcal strains remoted from difficult-to-treat pores and skin and smooth tissue infections
Persistent infections symbolize an essential burden on the healthcare system and have a major impression on the sufferers’ high quality of life. Whereas Staphylococcus spp. are commensal micro organism, they will grow to be pathogenic, main to varied sorts of infections. On this research we aimed to characterize the virulence profiles of staphylococcal strains concerned in difficult-to-treat pores and skin and smooth tissue infections, from each phenotypic and genotypic factors of view.
Phenotypic potential of the strains to secrete soluble virulence elements was assessed by a culturing dependent assay and their capability to develop biofilms on inert substrate was screened by an tailored crystal violet microtiter technique. We additionally examined the presence of a number of virulence genes by PCR. Many of the studied strains have been remoted from purulent secretions of zits lesions and incessantly secreted two or three soluble virulence elements.
Most incessantly secreted soluble virulence elements have been caseinase (89%), lipase (71%) and lecithinase (67%). Nearly half of the strains produced a well-represented biofilm. The molecular characterization confirmed the presence of the genes cna, hlg, clfA, and clfB. Staphylococcal strains that produce difficult-to-treat pores and skin and smooth tissue infections appear to be characterised by an enhanced potential to provide completely different soluble virulence elements and to develop biofilms in vitro. Additional research must be developed in different Staphylococcus spp. infections in an effort to affirm this speculation.
Performance of Receptor Focused Zinc-Insulin Quantum Clusters in pores and skin tissue augmentation and bioimaging
Quantum clusters with goal specificity are appropriate for tissue-specific imaging. Within the current work, amorphous zinc insulin quantum clusters (IZnQCs) had been synthesized to advertise and monitor wound restoration. Simple synthesis, biocompatibility, stability, enhanced quantum yield, and solubility made the cluster appropriate for preclinical/scientific exploration. Zn2+ is thought for its binding to insulin hexamer.
Right here we report the reformation of the construction in a quantum cluster kind within the presence of Zn2+. The formation of IZnQCs was confirmed by the change in zeta potential from -25.6 mV to -17.9 mV and in addition the formation of protein metallic interplay was confirmed in FTIR bands at 450, 480, and 613 cm-1 for Zn-O, Zn-N, and Zn-S respectively. HRTEM-EDS and SAED knowledge evaluation confirmed an amorphous nature of the cluster. The binding of IZnQCs to the cells has been confirmed utilizing confocal microscopy.
IZnQCs confirmed a synergistic impact in wound restoration than insulin or Zn2+ alone. Additional on account of excessive fluorescence this restoration course of might be monitored beneath an applicable setup. Wound therapeutic promotional exercise, goal specificity, and fluorescence properties make the IZnQCs ideally suited to make use of for bioimaging together with selling and monitoring of wound restoration agent.
Staphylococcal Pores and skin and Tender Tissue Infections
Staphylococcus aureus is the most typical micro organism inflicting purulent pores and skin and smooth tissue infections. Many disease-causing S aureus strains are methicillin resistant; thus, empiric remedy needs to be given to cowl methicillin-resistant S aureus. Bacterial wound cultures are essential for characterizing native susceptibility patterns. Definitive antibiotic remedy is warranted, though there are not any compelling knowledge demonstrating superiority of anybody antibiotic over one other.
 Paraffin Tissue Section - Human Bone Tumor |
|
T2235023 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Lung Tumor |
|
T2235152 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor |
|
T2235035 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Colon Tumor |
|
T2235090 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Liver Tumor |
|
T2235149 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adult Normal: Skin |
|
T2234218 |
Biochain |
5 slides |
EUR 185 |
 Paraffin Tissue Section - Human Breast Tumor |
|
T2235086 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Kidney Tumor |
|
T2235142 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Testis Tumor |
|
T2235260 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Tonsil Tumor |
|
T2235268 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adipose Tumor |
|
T2235003 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adrenal Tumor |
|
T2235004 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bladder Tumor |
|
T2235010 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Appendix Tumor |
|
T2235006 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Pancreas Tumor |
|
T2235188 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Prostate Tumor |
|
T2235201 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Abdominal Tumor |
|
T2235001 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Parathyroid Tumor |
|
T2235189 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Gallbladder Tumor |
|
T2235118 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Kidney Tumor: Wilms' Tumor |
|
T2235142-7 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Uterus Cervix Tumor |
|
T2235275 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adipose Tumor: Lipoma |
|
T2235003-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Angioma: Glomus Tumor |
|
T2235011-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bone Tumor: Chondroma |
|
T2235023-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adrenal Tumor: Adenoma |
|
T2235004-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Epndymoma |
|
T2235035-6 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Testis Tumor: Seminoma |
|
T2235260-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Gliocytoma |
|
T2235035-7 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Meningioma |
|
T2235035-9 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Pancreas Tumor: Islet Cell Tumor |
|
T2235188-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adrenal Tumor: Myelolipoma |
|
T2235004-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bone Tumor: Chondrosarcoma |
|
T2235023-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Lung Tumor: Adenocarcinoma |
|
T2235152-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma |
|
T2235090-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Liver Tumor: Adenocarcinoma |
|
T2235149-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Tumor Cell Line: MCF-7 |
|
T2255830 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Appendix Tumor: Adenocarcinoma |
|
T2235006-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Craniopharyngioma |
|
T2235035-4 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Pancreas Tumor: Adenocarcinoma |
|
T2235188-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Prostate Tumor: Adenocarcinoma |
|
T2235201-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bone Tumor: Synovial Sarcoma |
|
T2235023-8 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Ependymal Glioma |
|
T2235035-5 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Abdominal Tumor: Neuofibromatosis |
|
T2235001-7 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bone Tumor: Myeloma, Plasmacytic |
|
T2235023-7 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Breast Tumor: Lobular carcinoma |
|
T2235086-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma, MSH |
|
T2235090MSH |
Biochain |
5 slides |
EUR 734 |
 Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma, MSS |
|
T2235090MSS |
Biochain |
5 slides |
EUR 524 |
) Paraffin Tissue Section - Human Brain Tumor: Meningioma (Necrotic) |
|
T2235035-11 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section – Human Breast Tumor, BRCA Characterized |
|
T2235086BRCA |
Biochain |
5 slides |
EUR 524 |
 Paraffin Tissue Section - Human Rectum Tumor: Adenocarcinoma, MSS |
|
T2235206MSS |
Biochain |
5 slides |
EUR 524 |
 Paraffin Tissue Section - Human Uterus Tumor: Adenocarcinoma, MSS |
|
T2235274MSS |
Biochain |
5 slides |
EUR 524 |
) Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma (Ulcer) |
|
T2235090-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, MSS |
|
T2235248MSS |
Biochain |
5 slides |
EUR 524 |
 Paraffin Tissue Section - Human Parotid Tumor: Pleomorphic Adenoma |
|
T2235190-5 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Pilocytic Astrocytoma |
|
T2235035-13 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Breast Tumor: Mucous Adenocarcinoma |
|
T2235086-6 |
Biochain |
5 slides |
EUR 238 |
) Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma (Mucoid) |
|
T2235090-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bone Tumor: Giant Cell Tumor, Grade I-II |
|
T2235023-6 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Lung Tumor: Large Cell Carcinoma |
|
T2235152-6 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Lung Tumor: Small Cell Carcinoma |
|
T2235152-9 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Tonsil Tumor: Lymphoma of Tonsil |
|
T2235268-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Astrocytoma Grade I |
|
T2235035-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Astrocytoma Grade II |
|
T2235035-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV positive |
|
T2235275HPV+ |
Biochain |
5 slides |
EUR 646.8 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
 Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV negative |
|
T2235275HPV- |
Biochain |
5 slides |
EUR 646.8 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV negative |
|
T2235275HPV-negative |
Biochain |
5 slides |
EUR 524 |
Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV positive |
|
T2235275HPV-positive |
Biochain |
5 slides |
EUR 524 |
 Paraffin Tissue Section - Human Liver Tumor: Hepatocellular Carcinoma |
|
T2235149-4 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Pelvic Tumor: Malignant Mesothelioma |
|
T2235193-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Astrocytoma Grade III |
|
T2235035-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Kidney Tumor: Clear cell carcinoma |
|
T2235142-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Kidney Tumor: Renal Cell Carcinoma |
|
T2235142-5 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Colon Tumor: Non-hodgkin's lymphoma |
|
T2235090-9 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Lung Tumor: Squamous Cell Carcinoma |
|
T2235152-10 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section – Human Lung Tumor, EGFR/Kras Characterized |
|
T2235152EK |
Biochain |
5 slides |
EUR 524 |
 Paraffin Tissue Section - Human Abdominal Tumor: Cysto Teratocarcinoid |
|
T2235001-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Abdominal Tumor: Malignant Mesothelioma |
|
T2235001-6 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adrenal Tumor: Adrenal Pheochromocytoma |
|
T2235004-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bone Tumor: Chondroblastic Osteosarcoma |
|
T2235023-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Thyroid Tumor: Papillary Adenocarcinoma |
|
T2235265-7 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section – Human Colon Tumor, EGFR/Kras Characterized |
|
T2235090EK |
Biochain |
5 slides |
EUR 524 |
 Paraffin Tissue Section - Human Breast Tumor: Male Breast Hyperplasia |
|
T2235086-4 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Tumor: Lung, 10x Visium-Characterized |
|
T2235152-SV |
Biochain |
1 slide |
EUR 524 |
 Paraffin Tissue Section - Human Prostate Tumor: Neoplasia of Prostate |
|
T2235201-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Stomach Tumor: Squamous Cell Carcinoma |
|
T2235248-10 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Malignant Oligodendroglioma |
|
T2235035-8 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Liver Tumor: Cholangiocellular Carcinoma |
|
T2235149-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Uterus Tumor: Endometrium Adenocarcinoma |
|
T2235274-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Breast Tumor: Invasive ductal carcinoma |
|
T2235086-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Tumor: Breast, 10x Visium-Characterized |
|
T2235086-SV |
Biochain |
1 slide |
EUR 524 |
 Paraffin Tissue Section - Human Bone Tumor: Chondrosarcoma, Grade I - II |
|
T2235023-4 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Breast Tumor: Medullarycarcinoma of Breast |
|
T2235086-5 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Head & Neck Tumor: Squamouse Cell Carcinoma |
|
T2235121 |
Biochain |
5 slides |
EUR 233 |
 Paraffin Tissue Section - Human Lymph Nodes Tumor: Non-Hodgkin's Lymphoma |
|
T2235161-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Thyroid Tumor: Nodular Goiter of Thyroid |
|
T2235265-5 |
Biochain |
5 slides |
EUR 238 |
 CancerSeq™ Plus Paraffin Tissue Tumor Section: Lung |
|
T2235152-SC |
Biochain |
5 curls |
EUR 779 |
 Paraffin Tissue Section - Human Stomach Tumor: Signet-Ring Cell Carcinoma |
|
T2235248-9 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Bone Tumor: Chondrosarcoma, Well Differentiated |
|
T2235023-5 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Liver Tumor: Nodulous Hepatocellular Carcinoma |
|
T2235149-5 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Small Intestine Tumor: Duodenum Adenocarcinoma |
|
T2235226-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Kidney Tumor: Papillary Renal Cell Carcinoma |
|
T2235142-4 |
Biochain |
5 slides |
EUR 238 |
) Paraffin Tissue Section Panel - Human Tumor Same Tumor Type, Different Donors (5 tissues) |
|
T8235086 |
Biochain |
5 slides |
EUR 378 |
) Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235090 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235106 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235142 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235149 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235152 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235183 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235206 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235248 |
Biochain |
5 slides |
EUR 405 |
Paraffin Tissue Section Panel - Human Tumor, Same Tumor Type, Different Donors (5 tissues) |
|
T8235274 |
Biochain |
5 slides |
EUR 405 |
 Paraffin Tissue Section - Human Ovary Tumor: Mucous Papillary Cystoadenocarcinoma |
|
T2235183-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, Well Differentiated |
|
T2235248-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Angioma |
|
T2235011 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Colon Tumor: Diffuse Type Non-Hodgkin's Lymphoma |
|
T2235090-8 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Throat Tumor: Squamous Cell Carcinoma of Pharynx |
|
T2235263-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma Poorly Differentiated |
|
T2235248-1 |
Biochain |
5 slides |
EUR 238 |
: Colon) Matched Pair - Paraffin Tissue Section - Human Primary Tumor and Normal (PP): Colon |
|
T8235090-PP |
Biochain |
5 slides x2 |
EUR 375 |
: Liver) Matched Pair - Paraffin Tissue Section - Human Primary Tumor and Normal (PP): Liver |
|
T8235149-PP |
Biochain |
5 slides x2 |
EUR 375 |
: Lung) Matched Pair - Paraffin Tissue Section - Human Primary Tumor and Normal (PP): Lung |
|
T8235152-PP |
Biochain |
5 slides x2 |
EUR 375 |
 Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Poorly Differentiated |
|
T2235118-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Well Differentiated |
|
T2235118-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Pancreas Tumor: Adenocarcinoma, Moderately Differentiated |
|
T2235188-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, Moderately Differentiated |
|
T2235248-2 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Lymph Nodes Tumor: Non-Hodgkin's Lymphoma, T Cell |
|
T2235161-2 |
Biochain |
5 slides |
EUR 238 |
: Breast) Matched Pair - Paraffin Tissue Section - Human Primary Tumor and Normal (PP): Breast |
|
T8235086-PP |
Biochain |
5 slides x2 |
EUR 375 |
: Kidney) Matched Pair - Paraffin Tissue Section - Human Primary Tumor and Normal (PP): Kidney |
|
T8235142-PP |
Biochain |
5 slides x2 |
EUR 375 |
: Rectum) Matched Pair - Paraffin Tissue Section - Human Primary Tumor and Normal (PP): Rectum |
|
T8235206-PP |
Biochain |
5 slides x2 |
EUR 375 |
 Paraffin Tissue Section - Human Bladder Tumor: Papillary Transitional Cell Carcinoma |
|
T2235010-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Moderately Differentiated |
|
T2235118-1 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Lymph Nodes Tumor: Reactive Hyperplasia of Lymph Node |
|
T2235161-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Brain Tumor: Pituitary Adenoma with Oncocytic Cell Type |
|
T2235035-14 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Head & Neck Tumor: Squamouse Cell Carcinoma, HPV Positive |
|
T2235121HPV+ |
Biochain |
5 slides |
EUR 646.8 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
 Paraffin Tissue Section - Human Head & Neck Tumor: Squamouse Cell Carcinoma, HPV Negative |
|
T2235121HPV- |
Biochain |
5 slides |
EUR 646.8 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Paraffin Tissue Section - Human Head & Neck Tumor: Squamouse Cell Carcinoma, HPV Negative |
|
T2235121HPV-negative |
Biochain |
5 slides |
EUR 524 |
Paraffin Tissue Section - Human Head & Neck Tumor: Squamouse Cell Carcinoma, HPV Positive |
|
T2235121HPV-positive |
Biochain |
5 slides |
EUR 524 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel I, 5 tissue spots |
|
T8235417 |
Biochain |
5 slides |
EUR 363 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel II, 5 tissue spots |
|
T8235418 |
Biochain |
5 slides |
EUR 363 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel III, 5 tissue spots |
|
T8235419 |
Biochain |
5 slides |
EUR 363 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel IV, 5 tissue spots |
|
T8235420 |
Biochain |
5 slides |
EUR 363 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel V, 5 tissue spots |
|
T8235421 |
Biochain |
5 slides |
EUR 363 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel VI, 5 tissue spots |
|
T8235422 |
Biochain |
5 slides |
EUR 363 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel I, 8 tissue spots |
|
T8235437 |
Biochain |
5 slides |
EUR 565 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel II, 8 tissue spots |
|
T8235438 |
Biochain |
5 slides |
EUR 565 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel III, 8 tissue spots |
|
T8235439 |
Biochain |
5 slides |
EUR 565 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel IV, 8 tissue spots |
|
T8235440 |
Biochain |
5 slides |
EUR 565 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel V, 8 tissue spots |
|
T8235441 |
Biochain |
5 slides |
EUR 565 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel VI, 8 tissue spots |
|
T8235442 |
Biochain |
5 slides |
EUR 565 |
 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel VII, 8 tissue spots |
|
T8235443 |
Biochain |
5 slides |
EUR 565 |
 Paraffin Tissue Section - Human Brain Tumor: Oligodendroglioma and Astrocytoma, Mixed Glioma |
|
T2235035-12 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Esophagus Tumor: Squamous Cell Carcinoma, Poorly Differentiated |
|
T2235106-4 |
Biochain |
5 slides |
EUR 238 |
: Lung) Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Lung |
|
T8235152-PM |
Biochain |
5 slides x2 |
EUR 626 |
: Breast) Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Breast |
|
T8235086-PM |
Biochain |
5 slides x2 |
EUR 626 |
: Colon) Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Colon |
|
T8235090-PM |
Biochain |
5 slides x2 |
EUR 626 |
: Kidney) Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Kidney |
|
T8235142-PM |
Biochain |
5 slides x2 |
EUR 626 |
: Liver) Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Liver |
|
T8235149-PM |
Biochain |
5 slides x2 |
EUR 626 |
: Rectum) Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Rectum |
|
T8235206-PM |
Biochain |
5 slides x2 |
EUR 626 |
 Paraffin Tissue Section - Human Angioma: Hemangioma |
|
T2235011-3 |
Biochain |
5 slides |
EUR 238 |
 Section (5 SLIDES/PACK)) Paired Cancer and Normal Skin Paraffin Tissue (FFPE) Section (5 SLIDES/PACK) |
|
NCT236 |
TissueArray |
5 slides |
EUR 300 |
Paired Cancer and Normal Skin Paraffin Tissue (FFPE) Section (5 SLIDES/PACK) |
|
NCT241 |
TissueArray |
5 slides |
EUR 300 |
Paired Cancer and Normal Skin Paraffin Tissue (FFPE) Section (5 SLIDES/PACK) |
|
NCT246 |
TissueArray |
5 slides |
EUR 300 |
 Paraffin Tissue Section - Human Esophagus Tumor: Squamous Cell Carcinoma, Moderately Differentiated |
|
T2235106-3 |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adult Normal: Lung |
|
T2234152 |
Biochain |
5 slides |
EUR 185 |
 Paraffin Tissue Section - Human Diabetic Diseased Tissue: Lung |
|
T2236152Dia |
Biochain |
5 slides |
EUR 238 |
 Paraffin Tissue Section - Human Adult Normal: Brain |
|
T2234035 |
Biochain |
5 slides |
EUR 185 |
 Paraffin Tissue Section - Human Adult Normal: Colon |
|
T2234090 |
Biochain |
5 slides |
EUR 185 |
Antibiotic selection relies by the an infection severity, native susceptibility patterns, and drug-related security, tolerability, and value. Response to remedy is predicted inside the first days; 5 to 7 days of remedy is often sufficient to attain remedy.
